Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia.

Link to article at PubMed

Related Articles

Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia.

Cardiol Clin. 2018 May;36(2):277-285

Authors: Benes LB, Bassi NS, Kalot MA, Davidson MH

Abstract
Omega-3 fatty acids have shown modest benefit in certain subgroups at higher cardiovascular risk. Ongoing trials are investigating cardiovascular event rate reduction with newer, more efficacious formulations with a focus on these higher risk patients. This article focuses on the previously demonstrated benefits of omega-3 fatty acid therapies, currently available formulations, and their current and future role in reducing cardiovascular risk.

PMID: 29609757 [PubMed - in process]

Leave a Reply

Your email address will not be published.